← Eichor
Study identifier: NCT07163208 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Therapeutic Efficacy of Different Wavelengths of Low-Level Laser Therapy in the Treatment of Cervicogenic Headache

Condition: Cervicogenic Headache  ·  Sponsor: University of Lahore

PhaseNA
Planned participants150
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

This study tests if low-level laser therapy (LLLT) with different light wavelengths can help people with cervicogenic headache, a type of headache caused by neck problems. Adults aged 18-65 with this headache for at least 3 months will try one of three LLLT treatments (675nm, 820nm, or a mix of wavelengths) along with regular physical therapy like stretching and exercises. The study will check pain levels, how often headaches happen, neck movement, disability, and quality of life over 6 weeks, with follow-ups at 3 and 6 months. the investigators want to find the best LLLT option to reduce headache symptoms safely.

This description comes directly from the study's public registry record.

Talk to the study team

AROOJ MUNAWAR, MS  ·  00923214746780  ·  arooj.munawar@uipt.uol.edu.pk

Umair Ahmed, PhD  ·  00923212700817  ·  umair.ahmed@uipt.uol.edu.pk

Always discuss trial participation with your own doctor first.

Locations (1)

Department of Physiotherapy, Sir Ganga Ram HospitalLahore, Punjab Province, PakistanRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07163208